EP3134131
KJARNSÝRUBÓLUEFNI
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
23.4.2015EP published:
22.12.2021EP application number:
15783606.5
EP translation filed:
28.1.2022Grant published:
15.3.2022EPO information:
European Patent Register
Max expiry date:
22.4.2035Expiry date:
22.4.2026Next due date:
30.4.2026
Title in English:
NUCLEIC ACID VACCINESLanguage of the patent:
English
Timeline
Today
23.4.2015EP application
22.12.2021EP Publication
28.1.2022Translation submitted
15.3.2022Registration published
22.4.2026Expires
Owner
Name:
ModernaTX, Inc.Address:
200 Technology Square, Cambridge, MA 02139, US
Inventor
Name:
CIARAMELLA, GiuseppeAddress:
Sudbury, MA 01776, US
Name:
BOUCHON, AxelAddress:
14532 Kleinmachnow, DE
Name:
HUANG, Eric, Yi-ChunAddress:
Boston, MA 02118, US
Agent
Name:
Budde Schou A/SAddress:
Dronningens Tværgade 30, DK
Priority
Number:
201461983250 PDate:
23.4.2014Country:
US
Number:
201462088994 PDate:
8.12.2014Country:
US
Classification
Categories:
A61K 48/00, A61K 39/00, A61K 31/7105, A61K 9/16
Annual fees
Number
Paid
Expires
Payer
Number: 8
Paid: 10.3.2022
Expires: 22.4.2023
Payer: Árnason Faktor ehf.
Number: 9
Paid: 8.3.2023
Expires: 22.4.2024
Payer: Árnason Faktor ehf.
Number: 10
Paid: 7.3.2024
Expires: 22.4.2025
Payer: Árnason Faktor ehf.
Number: 11
Paid: 18.3.2025
Expires: 22.4.2026
Payer: Árnason Faktor ehf.